Jazz Pharmaceuticals plc — Director's Dealing 2015

Jun 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-06-09

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-09	Ordinary Shares	M	4000.0	$46.83	Acquired	50420	Direct
2015-06-09	Ordinary Shares	S	4000.0	$173.16	Disposed	46420	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-09	Non-Qualified Stock Option (right to buy)	$46.83	M	4000.0	Disposed	2022-08-08	Ordinary Shares (4000)	Direct

Footnotes

F1: Includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 25,417 shares and will vest with respect to 7,683 shares in equal monthly installments from July 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.